IL135799A0 - Immunological compositions and methods of use to transiently alter mammalian central nervous system myelin to promote neuronal regeneration - Google Patents
Immunological compositions and methods of use to transiently alter mammalian central nervous system myelin to promote neuronal regenerationInfo
- Publication number
- IL135799A0 IL135799A0 IL13579998A IL13579998A IL135799A0 IL 135799 A0 IL135799 A0 IL 135799A0 IL 13579998 A IL13579998 A IL 13579998A IL 13579998 A IL13579998 A IL 13579998A IL 135799 A0 IL135799 A0 IL 135799A0
- Authority
- IL
- Israel
- Prior art keywords
- methods
- nervous system
- central nervous
- neuronal regeneration
- mammalian central
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA 2219683 CA2219683A1 (fr) | 1997-10-28 | 1997-10-28 | Composition immunologique et methodes d'utilisation pour perturber transitoirement la myelin au systeme nerveux central de mammiferes pour promouvoir la regeneration des neuronnes |
CA2251410 | 1998-10-16 | ||
PCT/CA1998/000997 WO1999021581A1 (fr) | 1997-10-28 | 1998-10-28 | Compositions et procedes immunologiques utilises pour modifier provisoirement la myeline du systeme nerveux central des mammiferes afin de stimuler la regeneration neuronale |
Publications (1)
Publication Number | Publication Date |
---|---|
IL135799A0 true IL135799A0 (en) | 2001-05-20 |
Family
ID=25679779
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13579998A IL135799A0 (en) | 1997-10-28 | 1998-10-28 | Immunological compositions and methods of use to transiently alter mammalian central nervous system myelin to promote neuronal regeneration |
IL135799A IL135799A (en) | 1997-10-28 | 2000-04-24 | Immunological compositions to transiently alter mammalian central nervous system myelin to promote neuronal regeneration |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL135799A IL135799A (en) | 1997-10-28 | 2000-04-24 | Immunological compositions to transiently alter mammalian central nervous system myelin to promote neuronal regeneration |
Country Status (11)
Country | Link |
---|---|
US (2) | US6969516B1 (fr) |
EP (1) | EP1047449B1 (fr) |
JP (1) | JP2001521008A (fr) |
AT (1) | ATE249241T1 (fr) |
AU (1) | AU748143B2 (fr) |
DE (1) | DE69818106T2 (fr) |
DK (1) | DK1047449T3 (fr) |
ES (1) | ES2210829T3 (fr) |
IL (2) | IL135799A0 (fr) |
PT (1) | PT1047449E (fr) |
WO (1) | WO1999021581A1 (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002542299A (ja) * | 1999-04-28 | 2002-12-10 | ユニバーシティ・オブ・ブリティッシュ・コロンビア | ミエリン特異性抗体および補体タンパク質を含むニューロン再生用組成物 |
GB0103174D0 (en) * | 2001-02-08 | 2001-03-28 | Smithkline Beecham Plc | Novel method of treatment |
AR040778A1 (es) * | 2002-08-06 | 2005-04-20 | Glaxo Group Ltd | Anticuerpos alterados o fragmentos funcionales que se unen a mag (glicoproteina asociada a mielina). |
GB0306309D0 (en) | 2003-03-19 | 2003-04-23 | Glaxo Group Ltd | Method of treatment |
US8703136B2 (en) | 2006-10-10 | 2014-04-22 | Regenesance B.V. | Complement inhibition for improved nerve regeneration |
DK2649086T3 (en) * | 2010-12-09 | 2017-09-18 | Univ Pennsylvania | USING CHEMICAL ANTIGEN RECEPTOR-MODIFIED T-CELLS TO TREAT CANCER |
TWI654206B (zh) | 2013-03-16 | 2019-03-21 | 諾華公司 | 使用人類化抗-cd19嵌合抗原受體治療癌症 |
US10058471B2 (en) * | 2014-02-21 | 2018-08-28 | William M. Vaughan | System and method of using hyperbaric oxygen therapy for treating concussive symptoms and musculoskeletal injuries and for pre-treatment to prevent damage from injuries |
JP6765966B2 (ja) | 2014-04-07 | 2020-10-07 | ノバルティス アーゲー | 抗cd19キメラ抗原受容体を使用する癌の処置 |
SI3280729T1 (sl) | 2015-04-08 | 2022-09-30 | Novartis Ag | Terapije CD20, terapije CD22 in kombinacija terapij s celico, ki izraža himerni antigenski receptor CD19 (CAR) |
US10525083B2 (en) | 2016-10-07 | 2020-01-07 | Novartis Ag | Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding domain |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6174490A (en) * | 1989-08-04 | 1991-03-11 | Board Of Regents, The University Of Texas System | Methods and compositions; purified preparation of neural progenitor regulatory factor |
US6020140A (en) * | 1991-08-09 | 2000-02-01 | Washington University | Autoantibodies and their targets in the diagnosis of peripheral neuropathies |
ATE187889T1 (de) * | 1992-06-12 | 2000-01-15 | Cephalon Inc | Vorbeugung und behandlung der peripheren neuropathie |
US5714385A (en) * | 1995-05-10 | 1998-02-03 | Genentech, Inc. | Media for culturing schwann cells |
US6228598B1 (en) * | 1998-10-02 | 2001-05-08 | Washington University | Antibodies to heparan sulfate glycosaminoglycans in the diagnosis of polyneuropathies |
-
1998
- 1998-10-28 EP EP98949847A patent/EP1047449B1/fr not_active Expired - Lifetime
- 1998-10-28 WO PCT/CA1998/000997 patent/WO1999021581A1/fr active IP Right Grant
- 1998-10-28 DK DK98949847T patent/DK1047449T3/da active
- 1998-10-28 JP JP2000517739A patent/JP2001521008A/ja active Pending
- 1998-10-28 US US09/530,234 patent/US6969516B1/en not_active Expired - Fee Related
- 1998-10-28 AU AU96179/98A patent/AU748143B2/en not_active Ceased
- 1998-10-28 US US09/181,719 patent/US6548061B1/en not_active Expired - Fee Related
- 1998-10-28 ES ES98949847T patent/ES2210829T3/es not_active Expired - Lifetime
- 1998-10-28 DE DE69818106T patent/DE69818106T2/de not_active Expired - Lifetime
- 1998-10-28 IL IL13579998A patent/IL135799A0/xx active IP Right Grant
- 1998-10-28 PT PT98949847T patent/PT1047449E/pt unknown
- 1998-10-28 AT AT98949847T patent/ATE249241T1/de not_active IP Right Cessation
-
2000
- 2000-04-24 IL IL135799A patent/IL135799A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE69818106T2 (de) | 2004-06-17 |
DK1047449T3 (da) | 2004-01-26 |
AU748143B2 (en) | 2002-05-30 |
ATE249241T1 (de) | 2003-09-15 |
AU9617998A (en) | 1999-05-17 |
US6548061B1 (en) | 2003-04-15 |
IL135799A (en) | 2011-01-31 |
DE69818106D1 (de) | 2003-10-16 |
WO1999021581A1 (fr) | 1999-05-06 |
EP1047449A1 (fr) | 2000-11-02 |
EP1047449B1 (fr) | 2003-09-10 |
PT1047449E (pt) | 2004-04-30 |
JP2001521008A (ja) | 2001-11-06 |
ES2210829T3 (es) | 2004-07-01 |
US6969516B1 (en) | 2005-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL135799A0 (en) | Immunological compositions and methods of use to transiently alter mammalian central nervous system myelin to promote neuronal regeneration | |
DK1194167T3 (da) | Immunoterapi af autoimmune sygdomme under anvendelse af B-cellespecifikke antistoffer | |
NL300372I1 (nl) | Hybride immunoglobulinen voor gebruik bij therapeutische werkwijzen | |
DE69309472T2 (de) | Fusionsproteine von monomeren und dimeren von antikörperfragmenten | |
MX7235E (es) | Procedimiento para preparar una solucion inyectable intravenosamente de globulina de suero inmune | |
DE69119278T2 (de) | Monoklonaler Antikörper, der mit einer neuen HLA-Determinante auf MHC-Klasse-I-Moleküle reagiert, und Verfahren zur Aktivierung von Lymphozyten | |
ATE47155T1 (de) | Monoklonaler antikoerper. | |
PT743856E (pt) | Heteropolimeros a base de antigenes e metodo para o tratamento de doencas auto-imunes utilizando esses heteropolimeros | |
AR001811A1 (es) | Anticuerpos anti-icam-1 modificados y su uso en eltratamiento de inflamaciones | |
CY1107821T1 (el) | Πολυπεπτιδιο παραγοντα viii με ενεργοτητα παραγοντα viii:c | |
ES8603281A1 (es) | Un procedimiento para quemar hidrocarburos viscosos | |
ATE248605T1 (de) | Für e-selectin und p-selectin spezifische kreuzreaktive monoklonale antikörper | |
DK121788D0 (da) | Il-6, fremgangsmaade til dets fremstilling samt dets anvendelse | |
DE68918867T2 (de) | Mutanten des hiv-1 Hüllproteins mit fehlenden hypervariabelen domänen. | |
FI891528A0 (fi) | Antikroppheterokonjugat foer anvaendning vid reglering av lymfocytaktivitet. | |
AU4626389A (en) | Use of minoxidil for wound healing | |
CA2253078A1 (fr) | Composition immunologique et sa methode d'utilisation pour provoquer une demyelinisation transitoire dans le systeme nerveux central d'un mammifere afin de favoriser la regeneration des neurones | |
ATE236650T1 (de) | Verfahren zur hemmung der phagozytose | |
NO892125D0 (no) | Kombinasjon av angiotensin-omvandlende-enzymhemmere med kaliumkanal-modulatorer samt deres anvendelse i legemidler. | |
ES2013321A6 (es) | Un metodo de produccion de anticuerpos monoclonales | |
Stolinsky et al. | ON THE UNIVALENT FRAGMENTS OF HUMAN 7 S GAMMA-GLOBULIN. | |
Dose et al. | EFFECT OF UV‐IRRADIATION ON SEDIMENTATION BEHAVIOR OF VARIOUS PROTEINS | |
Ikuta et al. | Purification of C-reactive protein | |
KR870009805A (ko) | 미분기의 롤러 및 회전판의 재생방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted |